The lesser known effects of statins: benefits on infectious outcomes may be explained by "healthy user" effect - PubMed (original) (raw)

Editorial

The lesser known effects of statins: benefits on infectious outcomes may be explained by "healthy user" effect

Reimar W Thomsen. BMJ. 2006.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

• Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.
  Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Majumdar SR, et al. BMJ. 2006 Nov 11;333(7576):999. doi: 10.1136/bmj.38992.565972.7C. Epub 2006 Oct 23. BMJ. 2006. PMID: 17060337 Free PMC article.

References

1. 1. Heart Protection Study Collaborative Group. Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people. BMJ 2006 doi: 10.1136/bmj.38993.731725.BE - DOI
2. 1. Ehrenstein MR, Jury EC, Mauri C. Statins for atherosclerosis—as good as it gets? N Engl J Med 2005;352:73-5. - PubMed
3. 1. Rutishauser J. The role of statins in clinical medicine—LDL-cholesterol lowering and beyond. Swiss Med Wkly 2006;136:41-9. - PubMed
4. 1. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 2006;43:199-205. - PMC - PubMed
5. 1. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins: panacea for sepsis? Lancet Infect Dis 2006;6:242-8. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central

• Medical

  • MedlinePlus Health Information